Sulaymonov S.A., Nuriddinov N.N., Ochilov I.A. 2026. DAPAGLIFLOZIN AS PART OF COMBINATION THERAPY IN COPD COMORBID WITH HEART FAILURE: EFFECTS ON PULMONARY, CARDIAC, RENAL AND ENDOTHELIAL FUNCTION. International Multidisciplinary Journal for Research & Development. 13, 4 (Apr. 2026), 76–86.